Peptide therapy TikTok claims: what the science actually supports

What did @heatherafindlay actually say?

Heather kept it relatively measured for a peptide video. Her core message: talk to a doctor, get a reliable source, work out a personalized dosage, and budget realistically. She mentioned using peptides for "gut issues" she's had "pretty much my entire life" and priced her supply at somewhere between $100 and $400 for roughly two and a half months. She did not name a specific peptide, did not prescribe a dose, and did not claim she was cured of anything.

That restraint is worth noting. The peptide content space is full of people rattling off injection protocols and miracle recovery stories. Heather mostly avoided that. What she left out, though, matters as much as what she said.

Does the science back this up?

Partially, but the gap between "talk to a doctor" and "peptides fix gut issues" is bigger than this video suggests. The peptide most commonly linked to gastrointestinal repair in online wellness circles is BPC-157, a synthetic 15-amino-acid sequence derived from a gastric protein. Animal studies, including work by Sikiric et al. (2018, Current Pharmaceutical Design), show accelerated healing of gastric ulcers and intestinal anastomoses in rodent models. That is not nothing.

The problem is human trial data is essentially nonexistent. BPC-157 has not completed a single Phase II or Phase III clinical trial in humans as of mid-2024. The FDA has not approved it for any indication, and in 2022 the FDA explicitly added BPC-157 to its list of substances that cannot be compounded under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. So the "reliable source" Heather mentions is operating in a legally and clinically murky space regardless of how trustworthy the prescribing doctor seems.

What did they get wrong (or right)?

She got the framing right: "you must talk to a doctor" is the correct starting point, and insisting on medical oversight before using any injectable compound is responsible advice. Credit where it is due.

What she understated is regulatory reality. A "reliable source" for most peptides used in this space means a compounding pharmacy, not an FDA-approved manufacturer. Compounding quality varies significantly. A 2021 analysis published in JAMA Internal Medicine (Muluneh et al.) found that compounded sterile preparations failed potency or sterility standards at measurable rates across sampled pharmacies. Patients have no simple way to verify batch testing on their own.

She also frames peptide therapy as something a doctor will "assess" for your body, which implies a standard of individualized clinical evidence that does not yet exist for most peptides. Doctors prescribing these off-label are making judgment calls, not following clinical guidelines, and patients should understand that distinction.

What should you actually know?

If you are considering peptides for a GI condition, a few things are worth knowing before you book a telehealth consult.

• Most gut-related peptide use targets BPC-157 or TB-500. Neither has human efficacy data from randomized controlled trials. Animal data is promising but does not translate automatically.
• The FDA's 2022 restriction on BPC-157 compounding means any U.S. compounding pharmacy filling it is doing so outside standard regulatory channels. That is a real risk, not a technicality.
• "Affordable" is relative. Heather's $100-$400 range is accurate for what the market charges. But that cost is almost never covered by insurance, and there is no guarantee of efficacy.
• Chronic gut conditions like IBD, IBS, or SIBO have existing evidence-based treatment pathways. Peptides are not a substitute for a GI workup with a board-certified gastroenterologist.
• A doctor willing to prescribe peptides is not automatically a red flag, but you should ask whether they have access to certificate of analysis documentation from their compounding source.

The honest summary: Heather's advice is more responsible than most peptide content online, but the "talk to a doctor" framing can create false confidence in a category where the regulatory and clinical infrastructure most patients assume exists simply does not.